GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » TB SA Acquisition Corp (NAS:TBSAU) » Definitions » Research & Development

TB Acquisition (TB Acquisition) Research & Development : $0.00 Mil (TTM As of Sep. 2022)


View and export this data going back to 2021. Start your Free Trial

What is TB Acquisition Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. TB Acquisition's Research & Development for the three months ended in Sep. 2022 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2022 was $0.00 Mil.

TB Acquisition Research & Development Historical Data

The historical data trend for TB Acquisition's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TB Acquisition Research & Development Chart

TB Acquisition Annual Data
Trend Dec21
Research & Development
-

TB Acquisition Quarterly Data
Jan21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Research & Development Get a 7-Day Free Trial - - - - -

TB Acquisition Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TB Acquisition  (NAS:TBSAU) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

TB Acquisition Research & Development Related Terms

Thank you for viewing the detailed overview of TB Acquisition's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

TB Acquisition (TB Acquisition) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » TB SA Acquisition Corp (NAS:TBSAU) » Definitions » Research & Development
Comparable Companies
SEDA BGSX HPLT EDNC ORIA OPA SRSA FHLT TCAC PRLH
Traded in Other Exchanges
N/A
Address
Boundary Hall, Cricket Square, PO Box 1093, Grand Cayman, CYM, KY-11101
Website
TB SA Acquisition Corp is a blank check company. It is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
Executives
Neal Moszkowski 10 percent owner 65 EAST 55TH STREET, 19TH FLOOR, NEW YORK NY 10022
Ramez Sousou 10 percent owner 65 EAST 55TH STREET, 19TH FLOOR, NEW YORK NY 10022
Andrew Rolfe director, officer: Chief Executive Officer 4 BATTERYMARCH PARK, QUINCY MA 02169
Tcp Sa, Llc 10 percent owner UGLAND HOUSE, BOX 309, GRAND CAYMAN E9 KY1-1104
Gareth Penny director C/O TOWERBROOK CAPITAL, UGLAND HOUSE, BOX 309, GRAND CAYMAN E9 KY1-1104
Ziyanda Ntshona director C/O TOWERBROOK CAPITAL, UGLAND HOUSE, BOX 309, GRAND CAYMAN E9 KY1-1104
James Crawley officer: Chief Financial Officer C/O TOWERBROOK CAPITAL, UGLAND HOUSE, BOX 309, GRAND CAYMAN E9 KY1-1104
Radebe Healthcare Llc other: See Remarks C/O TOWERBROOK CAPITAL, UGLAND HOUSE, BOX 309, GRAND CAYMAN E9 KY1-1104
Thando Mhlambiso director C/O TOWERBROOK CAPITAL, UGLAND HOUSE, BOX 309, GRAND CAYMAN E9 KY1-1104